LOGO
LOGO

Ocular To Present Additional SOL-1 Phase 3 Trial Data On AXPAXLI At The VBS Annual Meeting

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
eye 09042026 lt

The Vit-Buckle Society (VBS) is a group of highly trained vitreoretinal surgeons who meet annually to share new and effective approaches to treating retinal diseases.

This year's VBS meeting marks the 14th annual gathering of its members and is scheduled for April 9 to 11 at the Fontainebleau Las Vegas.

Ocular Therapeutix Inc. (OCUL) is scheduled to present additional data and analyses from its SOL-1 phase 3 trial of Axpaxli in patients with wet age-related macular degeneration at the 14th Annual Vit-Buckle Society Meeting on April 11, 2026.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

RELATED NEWS
Latest Updates on COVID-19